XML 53 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2025
Segment Information  
Schedule of reportable segment information

March 31 

March 31 

    

2025

    

2024

Revenue

$

8,835

$

15,903

Less:

Cost of revenue

858

1,127

Research and development (1)

1,306

1,113

Sales

927

1,494

Sales operations

786

784

General and administration

4,873

2,847

Litigation contingency

29,750

Depreciation and amortization

120

176

Other segment expenses (2)

1,316

1,386

Segment operating (loss) profit

(31,101)

6,976

Interest (expense) income, net

(943)

819

Impairment of investments

(1,000)

Change in fair value of digital assets

(41,829)

Other corporate income (3)

4

2

(Loss) income before taxes

(74,869)

7,797

Income tax (benefit) expense

(10,167)

1,724

Net (loss) income

$

(64,702)

$

6,073

1.Research and development expenses include clinical affairs and HITRUST.
2.Other segment expenses include marketing, customer education and business development.
3.Other corporate income represents unallocated income